Emvenio Research
Emvenio Research, part of PCM Trials since February 2024, operates the largest independent DCT site network globally, focusing on empowering patients and embracing communities through localized trial access and strategic partnerships.
Services
Emvenio Research provides extensive services aimed at enhancing clinical trial participation and diversity. They operate community research sites, offer home and virtual visits, and focus on various therapeutic areas. With a patient-centric approach, Emvenio offers flexible and hybrid solutions tailored to specific study needs. Their network includes 45+ community research sites and a team of 190+ mobile clinicians. Emvenio also emphasizes compliance and safety, following CDC and NIH guidelines while ensuring robust training for research professionals.
Strategic Partnerships
Emvenio Research has established several strategic partnerships to broaden their impact and increase diversity in clinical trials. They partner with Health Wizz to offer clinical research as a care option and collaborate with Walgreens and Boehringer Ingelheim to improve diversity in their trials. Additionally, Emvenio has a strategic partnership with Prime Healthcare to further their mission. These collaborations are crucial for expanding localized trial access to diverse and underserved communities.
Community Engagement
Emvenio Research is committed to community engagement and actively participates in community events to promote well-being and awareness about clinical research. They provide free wellness and obesity screenings in Oklahoma City and host various events such as the Community Research Site Reception at the SCOPE Summit. Emvenio’s activities aim to empower patients and embrace communities, ensuring better retention and access to clinical trials.
Clinical Trial Locations
Emvenio Research operates a network of 23 community research sites across the United States and the United Kingdom. Their locations are chosen based on data-driven decisions to optimize site placement for clinical trials. Emvenio provides mobile community research sites equipped with features like 24/7 temperature monitoring and HEPA filtration to ensure safety and security. This setup enhances patient access and improves diversity in clinical trials.
Therapeutic Areas Focus
Emvenio Research focuses on a variety of therapeutic areas to support clinical trials. These areas include metabolic/immunology, infectious disease, neurology, respiratory, gastrointestinal, dermatology, cardiology, women's health, in-vitro diagnostics, and rare/orphan diseases. Their specialized knowledge and dedicated resources in these areas allow for targeted and effective clinical trials, ensuring comprehensive coverage of diverse medical needs.